Osteoarthritis

Osteoarthritis (OA) is a chronic, progressive, and degenerative disorder of synovial joints characterized by articular cartilage loss, subchondral bone remodeling, osteophyte formation, synovial inflammation, and variable degrees of joint effusion and periarticular soft tissue fibrosis. In veterinary surgery, OA is the most common cause of chronic lameness in dogs and cats, often secondary to joint instability, trauma, developmental abnormalities (e.g., hip dysplasia, elbow dysplasia), or previous inflammatory joint disease. The disease process involves a complex interplay of biomechanical stress, biochemical degradation, and inadequate repair mechanisms, leading to pain, dysfunction, and reduced quality of life. Surgical management is indicated when medical therapy fails, when there is significant joint instability, or when salvage procedures (e.g., arthrodesis, femoral head and neck excision) are required to alleviate pain. OA is classified as primary (idiopathic) or secondary (due to an identifiable cause), with the latter being far more common in animals. Staging systems, such as the International Cartilage Repair Society (ICRS) grading for cartilage lesions and the Osteoarthritis Research Society International (OARSI) histopathological grading, are used to assess severity and guide treatment decisions.

The etiology of osteoarthritis in veterinary patients is multifactorial. Primary OA is rare and typically associated with aging and genetic predisposition. Secondary OA arises from identifiable causes: (1) Developmental abnormalities: hip dysplasia, elbow dysplasia (fragmented coronoid process, osteochondritis dissecans, ununited anconeal process), patellar luxation, and Legg-Calvé-Perthes disease. (2) Traumatic injuries: intra-articular fractures, ligamentous ruptures (cranial cruciate ligament rupture, collateral ligament injuries), meniscal tears, and joint luxation. (3) Infectious arthritis: bacterial, fungal, or rickettsial infections that cause cartilage degradation and synovial inflammation. (4) Immune-mediated arthritis: rheumatoid arthritis, systemic lupus erythematosus, and polyarthritis of unknown origin. (5) Neoplastic conditions: synovial cell sarcoma, osteosarcoma, or metastatic disease affecting the joint. (6) Iatrogenic causes: previous joint surgery, improper implant placement, or excessive joint immobilization. Biomechanically, abnormal joint loading leads to chondrocyte apoptosis, matrix metalloproteinase (MMP) activation, and release of pro-inflammatory cytokines (IL-1, TNF-α), resulting in progressive cartilage erosion and subchondral bone sclerosis.

Osteoarthritis is the most prevalent joint disease in dogs, affecting approximately 20% of the canine population, with higher incidence in large and giant breeds. In cats, OA is underdiagnosed but affects up to 60% of cats over 6 years of age, with a predilection for the elbow, hip, and stifle joints. Breed predispositions include Labrador Retrievers, Golden Retrievers, German Shepherds, Rottweilers, and Bernese Mountain Dogs for hip and elbow dysplasia. Working and sporting dogs (e.g., agility, hunting, and police dogs) have increased risk due to high-impact activity. Age of onset varies: developmental OA may appear as early as 6-12 months, while degenerative OA typically manifests in middle-aged to older animals. Sex predilection is not consistent, but some studies suggest a slight male predisposition for hip dysplasia. Obesity is a significant risk factor, as excess body weight increases joint loading and adipokine-mediated inflammation. Genetic factors, such as polymorphisms in the fibrillin-2 gene, have been associated with hip dysplasia in certain breeds.

The pathophysiology of osteoarthritis involves a cascade of events initiated by mechanical stress or biochemical insult. Chondrocytes respond to abnormal loading by proliferating and increasing synthesis of proteoglycans and collagen, but this reparative response is overwhelmed, leading to net matrix degradation. Key enzymes, including matrix metalloproteinases (MMP-1, MMP-3, MMP-13) and aggrecanases (ADAMTS-4, ADAMTS-5), are upregulated by pro-inflammatory cytokines (IL-1β, TNF-α) released from synovial macrophages and chondrocytes. This results in depletion of aggrecan and type II collagen, leading to cartilage fibrillation, fissuring, and eventual full-thickness erosion. Subchondral bone undergoes remodeling with increased turnover, sclerosis, and cyst formation. Osteophytes form at joint margins due to periosteal stimulation. Synovitis develops with infiltration of macrophages and lymphocytes, contributing to pain and effusion. Neurovascular invasion of the subchondral bone and synovium leads to nociceptor sensitization and chronic pain. Systemic inflammatory markers (CRP, SAA) may be elevated. In advanced stages, joint capsule fibrosis and muscle atrophy contribute to decreased range of motion and functional impairment.

Intrinsic factors include: (1) Genetic predisposition: certain breeds have inherited conformational traits (e.g., hip laxity) that predispose to OA. (2) Age: aging leads to decreased chondrocyte synthetic capacity and increased matrix stiffness. (3) Obesity: increased body weight and adipokine secretion (leptin, resistin) promote inflammation and cartilage degradation. (4) Sex: some studies suggest neutered animals have higher risk, possibly due to hormonal changes. (5) Joint conformation: abnormal joint angles (e.g., patellar luxation, elbow incongruity) increase focal stress. Extrinsic factors include: (1) Trauma: acute injuries such as fractures, ligament tears, and meniscal damage. (2) Nutrition: excessive calcium and vitamin D intake during growth may contribute to developmental orthopedic disease. (3) Management: high-impact exercise, repetitive stress, and hard surfaces. (4) Prior surgery: joint surgery can alter biomechanics and accelerate OA. (5) Infectious or immune-mediated arthritis: these conditions cause direct cartilage damage and synovial inflammation.

Clinical signs of osteoarthritis vary with severity and affected joint. Early signs include mild intermittent lameness, stiffness after rest (especially in the morning), and reluctance to jump or climb stairs. As disease progresses, lameness becomes more consistent, with weight-bearing impairment and muscle atrophy. On orthopedic examination, joint effusion, thickening of the joint capsule, and crepitus may be palpable. Pain is elicited on flexion, extension, or manipulation of the joint. Range of motion is decreased. In hip OA, signs include pain on hip extension and abduction, and a positive Ortolani sign in cases of hip laxity. In stifle OA due to cranial cruciate ligament rupture, cranial drawer sign and tibial thrust are positive. Cats with OA often show subtle signs such as reduced activity, decreased grooming, and inappropriate elimination due to difficulty accessing litter boxes. Lameness grading scales (e.g., 0-5) are used to quantify severity. Systemic signs are rare but may include lethargy and decreased appetite in severe cases.

Differential diagnoses for osteoarthritis include: (1) Cranial cruciate ligament rupture: acute onset, positive cranial drawer sign, joint effusion, and radiographic evidence of stifle OA; MRI or arthroscopy can confirm. (2) Hip dysplasia: developmental, with hip laxity, pain on extension, and radiographic signs of subluxation and remodeling; OA is a sequela. (3) Elbow dysplasia: includes fragmented coronoid process, osteochondritis dissecans, and ununited anconeal process; imaging (CT, arthroscopy) is diagnostic. (4) Septic arthritis: acute severe lameness, joint swelling, fever, and neutrophilic synovial fluid with positive culture. (5) Immune-mediated polyarthritis: multiple joints affected, systemic signs, and synovial fluid with high nucleated cell count and negative culture. (6) Osteochondritis dissecans: young large-breed dogs, cartilage flap on radiographs or arthroscopy. (7) Joint neoplasia (e.g., synovial cell sarcoma): progressive swelling, bone lysis on radiographs, and histopathology. (8) Patellar luxation: medial or lateral displacement of the patella, palpable, and radiographic confirmation. (9) Fracture or luxation: history of trauma, acute lameness, and radiographic evidence. (10) Panosteitis: shifting leg lameness in young dogs, radiographic medullary sclerosis.

The diagnostic algorithm for osteoarthritis begins with a thorough history and physical examination, including orthopedic and neurological assessments. Gait analysis (e.g., visual observation, pressure-sensitive walkway) helps quantify lameness. Palpation of joints for effusion, thickening, crepitus, and pain is essential. Radiography is the first-line imaging modality: standard views (e.g., ventrodorsal hip extended, lateral stifle) and stress views (e.g., PennHIP for hip laxity) are obtained. Radiographic signs of OA include joint effusion, osteophytes, subchondral sclerosis, and joint space narrowing. If radiographs are inconclusive or surgical planning is needed, advanced imaging such as CT (for elbow dysplasia, complex fractures) or MRI (for cartilage, meniscal, and soft tissue evaluation) is recommended. Arthroscopy is the gold standard for direct visualization of articular cartilage and synovium, allowing biopsy and minimally invasive treatment. Synovial fluid analysis is performed to rule out septic or immune-mediated arthritis. In cases of suspected secondary OA, specific diagnostic tests (e.g., genetic testing for hip dysplasia, culture for infectious agents) are pursued. The algorithm progresses from non-invasive to invasive modalities based on clinical suspicion and therapeutic planning.

Laboratory findings in osteoarthritis are typically non-specific. Synovial fluid analysis is crucial: normal synovial fluid is clear, viscous, with a mucin clot good, and nucleated cell count < 3,000/μL. In OA, fluid may be slightly turbid, viscosity decreased, mucin clot fair to poor, and nucleated cell count mildly elevated (3,000-10,000/μL) with predominantly mononuclear cells (macrophages, lymphocytes). Neutrophils are < 10%. If septic arthritis is suspected, culture and sensitivity are performed. Hematology and biochemistry are usually within normal limits, but may show mild leukocytosis in inflammatory conditions. Inflammatory biomarkers such as C-reactive protein (CRP) and serum amyloid A (SAA) may be elevated in acute flares. Coagulation panel (PT, aPTT, TEG) is recommended before surgery to assess bleeding risk. Urinalysis and blood gas analysis are part of the pre-anesthetic workup, especially in geriatric patients. In immune-mediated arthritis, antinuclear antibody (ANA) and rheumatoid factor (RF) tests may be positive.

Radiography is the primary imaging modality for osteoarthritis. Findings include: joint effusion (soft tissue swelling), osteophyte formation at joint margins, subchondral bone sclerosis, subchondral cysts, and joint space narrowing. In hip dysplasia, the Norberg angle is < 105°, and the distraction index (DI) is > 0.3 on PennHIP. In elbow dysplasia, CT is superior for detecting fragmented coronoid process and incongruity. MRI provides detailed assessment of articular cartilage (e.g., T2 mapping, delayed gadolinium-enhanced MRI of cartilage), meniscal tears, and subchondral bone edema. Ultrasonography can evaluate joint effusion and periarticular soft tissues, but is limited for intra-articular structures. Arthroscopy allows direct visualization of cartilage lesions (graded I-IV), synovial hypertrophy, and meniscal damage. Fluoroscopy is used for dynamic assessment of joint instability. In cases of suspected neoplasia, angiography or contrast-enhanced CT may be used. Advanced imaging is essential for surgical planning, especially for corrective osteotomies or arthrodesis.

Synovial fluid cytology in OA shows a mild increase in nucleated cell count (3,000-10,000/μL) with a predominance of large mononuclear cells and occasional neutrophils. No bacteria are seen. Histopathology of articular cartilage reveals fibrillation, fissuring, and loss of proteoglycan staining (Safranin O). Chondrocyte cloning (clusters) is a hallmark. Subchondral bone shows sclerosis and cyst formation. Synovial membrane exhibits villous hyperplasia, mild lymphocytic infiltration, and fibrosis. In cases of secondary OA due to neoplasia, biopsy of the synovium or bone is diagnostic. Histopathological grading systems (e.g., OARSI) are used to assess severity. Surgical biopsy may be obtained during arthroscopy or open arthrotomy. Special stains (e.g., Masson's trichrome for collagen, Alcian blue for proteoglycans) aid in evaluation.

Treatment of osteoarthritis is multimodal, combining medical management and surgical intervention. Medical therapy includes weight management, exercise modification, physical rehabilitation, and pharmacologic agents (NSAIDs, analgesics, chondroprotectants). Surgical treatment is indicated when medical therapy fails, or when there is a correctable underlying cause. Specific surgical options depend on the joint and etiology: (1) For hip OA secondary to hip dysplasia: juvenile pubic symphysiodesis (in young dogs), triple pelvic osteotomy (TPO) in young dogs with minimal OA, femoral head and neck excision (FHNE) as a salvage procedure, or total hip replacement (THR) for advanced OA. (2) For stifle OA due to cranial cruciate ligament rupture: tibial plateau leveling osteotomy (TPLO), tibial tuberosity advancement (TTA), or lateral suture stabilization. (3) For elbow OA: arthroscopic removal of fragmented coronoid process, or subtotal coronoidectomy; in severe cases, arthrodesis or total elbow replacement. (4) For patellar luxation: trochleoplasty, tibial tuberosity transposition, and soft tissue release. (5) For OA due to trauma: fracture repair, ligament reconstruction, or arthrodesis. Surgical techniques require meticulous soft tissue handling, appropriate implant selection (e.g., plates, screws, external fixators), and postoperative pain management. Suture materials for soft tissue repair include polydioxanone (PDS) or polypropylene for capsular closure. Postoperative protocols include restricted activity, physical therapy (passive range of motion, therapeutic ultrasound, underwater treadmill), and analgesic administration.

Prognosis for osteoarthritis varies depending on the underlying cause, severity, and treatment. With appropriate medical management, many animals maintain acceptable quality of life for years. Surgical interventions such as TPLO for cruciate disease have success rates of 85-90% in returning to near-normal function. Total hip replacement has a 90-95% success rate with good to excellent outcomes. FHNE provides pain relief but with reduced range of motion and limb function, especially in large dogs. Arthrodesis is a salvage procedure that eliminates pain but results in permanent loss of joint motion. Negative prognostic indicators include severe cartilage damage, advanced age, obesity, and concurrent orthopedic disease. Complications such as implant failure, infection, and delayed healing can worsen prognosis. Long-term management is often required, with ongoing pain medication and rehabilitation.

Postoperative follow-up is critical. Suture removal is typically 10-14 days after surgery. Serial radiographs are obtained at 4, 8, and 12 weeks to assess bone healing and implant position. For TPLO, radiographs at 8 weeks confirm osteotomy healing. Restricted activity (leash walks only) is recommended for 6-8 weeks, with gradual increase in exercise. Physical therapy protocols include passive range of motion exercises (3-5 times daily), massage, and controlled weight-bearing activities. Recheck examinations at 4, 8, 12, and 24 weeks assess lameness, range of motion, and muscle mass. Long-term monitoring for OA progression is recommended every 6-12 months, with adjustments to medication and rehabilitation as needed. Owners are educated on signs of complications (e.g., swelling, fever, non-weight-bearing lameness) and the importance of weight management.

Pearls: (1) Early diagnosis and intervention improve outcomes; use PennHIP for hip dysplasia screening. (2) In TPLO, accurate preoperative measurement of tibial plateau angle (TPA) is crucial; aim for a postoperative TPA of 5-7°. (3) In FHNE, ensure complete excision of the femoral neck to prevent bone-on-bone contact. (4) Use arthroscopy to assess cartilage lesions and perform minimally invasive debridement. (5) Postoperative pain management with multimodal analgesia (opioids, NSAIDs, local blocks) is essential. Pitfalls: (1) Failure to address underlying instability (e.g., cruciate rupture) leads to progressive OA. (2) In TPLO, improper plate placement or screw penetration into the joint can cause catastrophic failure. (3) Overweight patients have higher complication rates; address obesity preoperatively. (4) In arthrodesis, inadequate joint surface preparation or fixation leads to nonunion. (5) Avoid prolonged use of NSAIDs in patients with renal or hepatic disease; monitor renal values.

Perioperative drug protocols are based on Plumb's Veterinary Drug Handbook. Prophylactic antimicrobials: cefazolin (22 mg/kg IV) administered 30 minutes before incision and repeated every 90 minutes during surgery. Postoperative antibiotics are not routinely needed unless infection is present. Analgesics: (1) Opioids: morphine (0.5-1 mg/kg IM or IV q4-6h), hydromorphone (0.05-0.1 mg/kg IV q4-6h), or fentanyl CRI (2-5 μg/kg/h) for severe pain. (2) NSAIDs: carprofen (2.2 mg/kg PO q12h), meloxicam (0.1 mg/kg PO q24h), or robenacoxib (1-2 mg/kg PO q24h) for 3-7 days postoperatively, then as needed. (3) Local anesthetics: bupivacaine (1-2 mg/kg) for intra-articular or incisional blocks. (4) Adjuncts: gabapentin (10-20 mg/kg PO q8-12h) for neuropathic pain, amantadine (3-5 mg/kg PO q24h) for chronic pain. Chondroprotectants: polysulfated glycosaminoglycan (4.4 mg/kg IM or SC twice weekly for 4 weeks), glucosamine/chondroitin supplements (e.g., 500-1000 mg glucosamine PO q24h). Muscle relaxants: methocarbamol (15-20 mg/kg PO q8h) for muscle spasms. Dosages should be adjusted for renal or hepatic impairment. Always monitor for gastrointestinal and renal side effects.

Key studies: (1) The Canine Osteoarthritis Staging System (COAST) provides a standardized framework for diagnosis and treatment. (2) A prospective randomized trial by Gordon-Evans et al. (2013) compared TPLO and lateral suture for cranial cruciate ligament rupture, showing similar functional outcomes at 6 months. (3) A meta-analysis by Bergh et al. (2014) found that total hip replacement provides superior function compared to FHNE in dogs with hip OA. (4) The PennHIP method has been validated for early detection of hip laxity and prediction of OA. (5) A study by Moreau et al. (2014) demonstrated that a multimodal approach including weight loss, exercise, and NSAIDs improves quality of life in osteoarthritic dogs. (6) ACVS consensus statements recommend surgical intervention for joint instability to prevent progression of OA. (7) A systematic review by Aragon et al. (2007) concluded that therapeutic exercise is beneficial for pain relief and function in OA. These studies support evidence-based decision-making in veterinary surgical practice.